Correspondence 0001104659-23-100384 from Envoy Medical, Inc. (COCH, COCHW) (CIK 0001840877) (COCH)
Envoy Medical, Inc. (COCH, COCHW) (CIK 0001840877)
Date: Sept. 13, 2023 · CIK: 0001840877 · Accession: 0001104659-23-100384
AI Filing Summary & Sentiment
File numbers found in text: 333-271920
Show Raw Text
CORRESP
1
filename1.htm
ANZU SPECIAL ACQUISITION
CORP I
12610 Race Track Road,
Suite 250
Tampa, Florida 33626
September 13, 2023
VIA EDGAR
Benjamin Richie
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: Anzu Special Acquisition Corp I
Registration Statement
on Form S-4 (File No. 333-271920)
Dear Mr. Richie:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Anzu Special Acquisition Corp I (the “Registrant”) hereby requests acceleration of effectiveness
of its registration statement on Form S-4 (File No. 333-271920) to 4:05 p.m., Eastern Time, on September 14, 2023
or as soon as practicable thereafter.
The Registrant requests that it be notified of
such effectiveness by a telephone call to David P. Slotkin, the Company’s counsel at Morrison & Forester LLP, at (202)
887-1554.
Very truly yours,
Anzu Special Acquisition Corp I
By:
/s/ Daniel J. Hirsch
Name:
Daniel J. Hirsch
Title:
Chief Financial Officer